More than 25 inherited human disorders are caused by the unstable expansion of repetitive DNA sequences termed short tandem repeats (STRs). A fundamental unresolved question is why some STRs are susceptible to pathologic expansion, whereas thousands of repeat tracts across the human genome are relatively stable. Here, we discover that nearly all disease-associated STRs (daSTRs) are located at boundaries demarcating 3D chromatin domains. We identify a subset of boundaries with markedly higher CpG island density compared to the rest of the genome. daSTRs specifically localize to ultra-high-density CpG island boundaries, suggesting they might be hotspots for epigenetic misregulation or topological disruption linked to STR expansion. Fragile X syndrome patients exhibit severe boundary disruption in a manner that correlates with local loss of CTCF occupancy and the degree of FMR1 silencing. Our data uncover higherorder chromatin architecture as a new dimension in understanding repeat expansion disorders.
INTRODUCTION
Unstable expansion of repetitive DNA sequences termed short tandem repeats (STRs) serves as the mechanistic basis for more than 25 inherited human disorders, including fragile X syndrome, Huntington's disease, amyotrophic lateral sclerosis, and Friedreich's ataxia (La Spada and Taylor, 2010; McMurray, 2010; Mirkin, 2007; Nelson et al., 2013; Pearson et al., 2005) . Patients with unstable repeat expansion disorders suffer from a complex array of symptoms, including cardiac defects, cataracts, anxiety, hyperactivity, low IQ, social deficits, respiratory defects, and seizures (Orr and Zoghbi, 2007 ). An increased understanding of the molecular mechanisms governing STR instability would facilitate efforts to develop treatments for repeat expansion disorders.
Healthy individuals have tens of thousands of relatively short STR tracts distributed throughout their genomes (Gymrek and Erlich, 2013; Gymrek et al., 2016; Willems et al., 2017) . Normal-length STR tracts are generally stable across generations and among somatic tissues in the same individual (McMurray, 2010) . By a process that is poorly understood, a small number of specific normal-length STRs undergo somatic or germline expansion and transition to intermediate, premutation, and mutation (affected) repeat unit tract lengths (Mirkin, 2007; Pearson et al., 2005) . A fundamental unresolved question is why STRs at some key genomic locations are susceptible to unstable expansion leading to severe pathology, whereas most normal-length STRs across the genome remain relatively stable.
Disease-associated STR tracts (hereafter referred to as daSTRs) exhibit tremendous diversity in sequence, gene body location, and tract length. daSTRs consist predominantly of a trinucleotide unit, but expandable tetra-, penta-, and hexanucleotide repeat sequences have also been reported (Iyer et al., 2015) . Pre-mutation and mutation lengths vary widely among the repeat expansion disorders (Iyer et al., 2015; McMurray, 2010) . daSTRs also exhibit a wide range of repeat unit sequences and can be localized across the gene body in introns, exons, promoters, and 3 0 /5 0 untranslated regions (UTRs) (La Spada and Taylor, 2010) . The diversity of daSTR features renders them challenging to study and raises the question of whether a unified model could exist to explain the mechanisms governing repeat instability.
Mammalian genomes are organized into a hierarchy of megabase (Mb)-scale topologically associating domains (TADs) (Dixon et al., 2012; Nora et al., 2012) and smaller, nested subTADs (Dixon et al., 2012; Nora et al., 2012; Phillips-Cremins et al., 2013; Rao et al., 2014) . TADs/subTADs are defined as contiguous intervals in the genome in which every pair of loci has an elevated interaction frequency compared to loci outside the domain. Such chromatin domains span >90% of the genome and are thought to create insulated neighborhoods demarcating the search space of specific long-range interactions between enhancers and their target genes (Dowen et al., 2014; Narendra et al., 2015; Symmons et al., 2014) . Linker regions termed boundaries separate TADs/subTADs. Boundary disruption has recently been linked to cancer and diseases of limb development (Flavahan et al., 2016; Hnisz et al., 2016; Lupiá ñ ez et al., 2015) , but the role for TADs in neurological disorders has not yet been reported.
Here, we discover a link between 3D genome folding and repeat expansion disorders. Although daSTRs exhibit tremendous diversity in sequence, gene body location, and mutation-length threshold, we find that nearly all are spatially co-localized to boundaries between chromatin domains. Boundaries can be stratified into at least two groups: (1) those with high CpG island density and high occupancy of the architectural protein CCCTC binding factor (CTCF), and (2) those depleted of CpG island density. We demonstrate that nearly all daSTRs are specifically targeted to CpG island-rich boundaries, but not boundaries devoid of CpG islands or CpG islands internal to domains. Notably, we observe severe boundary disruption in B cells, fibroblasts, and postmortem brain tissue derived from patients with fragile X syndrome. The extent of boundary disruption correlates with the degree of FMR1 silencing and loss of CTCF occupancy at specific sites adjacent to the FMR1 daSTR. Together, these data support a working model in which the unique genetic, epigenetic, and topological state at a critical subset of 3D chromatin domain boundaries might earmark locations in the genome with increased susceptibility to STR instability in human disease.
RESULTS daSTRs Co-localize with Chromatin Domain Boundaries in Human ESCs
To understand higher-order 3D genome folding patterns around daSTR loci, we analyzed Hi-C maps generated from human ESCs (Dixon et al., 2015) and human fetal cortical plate tissue (Won et al., 2016) . Because the samples are not diseased, we mapped daSTRs to the normal-length repeat tracts found in the hg19 reference genome (Tables S1, S2 , and S3). To quantitatively determine the precise location of Mb-scale TAD boundaries, we used a well-established method based on the directionality index (DI) test statistic and a hidden Markov model (DI+HMM) (Dixon et al., 2012 (Dixon et al., , 2015 . Consistent with previous reports (STAR Methods), we identified 2,384 TADs in human ESCs using a DI window of 50 (Dixon et al., 2012 (Dixon et al., , 2015 (Table S4) . Surprisingly, we observed that 11 out of 27 daSTR loci exhibit striking co-localization with boundaries of TADs, including FMR1 (fragile X syndrome), HTT (Huntington's disease), DMPK (Myotonic dystrophy 1), FXN (Friedreich's ataxia), C9orf72 (amyotrophic lateral sclerosis), and ATXN1 (spinocerebellar ataxia 1) (Figures 1A and S1A) .
We next set out to understand the daSTRs initially classified as distal from TAD boundaries. We used a new method recently developed by our lab, 3DNetMod (Norton et al., 2018) , to identify a nested hierarchy of 15,330 subTADs in human ESCs (detailed in the STAR Methods). We detected an additional 11 out of 27 daSTRs at subTAD boundaries, including RUNX2 (cleidocranial dysplasia), ZIC2 (holoprosencephaly), and CACNA1A (spinocerebellar ataxia 6) ( Figures 1B and S1B) . Notably, 4 of the 5 daSTR loci that did not exhibit adjacency to quantitatively called domain boundaries were still co-localized at visually evident domain borders (Figures S1C and S1D). We can attribute the false-negative boundaries missed by 3DNetMod to our decision to use rigorous thresholds that minimize false-positive domain detection. Thus, our observation of 22 out of 27 daSTR loci at human ESC boundaries is a conservative estimate. Together, our analyses indicate that the majority of daSTRs currently reported as susceptible to unstable expansion in human disease are spatially co-localized to boundaries of 3D genome domains in human ESCs ( Figure 1C ).
daSTRs Localize to Boundaries Significantly More Than Normal-Length Repeats Genome-wide We next set out to determine how the boundary localization of daSTRs compared to the genome-wide expectation of matched normal-length repeats. To ensure a rigorous null model, we compared the daSTR loci in hg19 to all other normal-length STR tracts genome-wide matched by repeat unit sequence, normal-length range, and gene body placement (Tables S1  and S2 ; STAR Methods). We found that daSTRs are significantly closer to domain boundaries compared to matched repeat tracts (0 bp versus 5,203 bp median; p = 0.00074 Mann-Whitney U test; p = 0.0037, Kolmogorov-Smirnov test) (Figure 2A ). Moreover, daSTRs showed significantly higher enrichment at domain boundaries compared to other normal-length, matched repeat sequences (odds ratio = 4.77, Fisher's exact test, p = 0.00056, Figure 2B ). We confirmed that the effect was largely unchanged (odds ratio = 4.23) when performing the Cochran-Mantel-Haenszel test. This striking boundary enrichment is a conservative estimate given that some daSTRs are located at visually apparent domain boundaries missed by the conservative thresholds used in this manuscripts' domain-calling analysis.
We also computed bootstrapped confidence intervals for the percentage of repeat tracts located at boundaries (STAR Methods). The mean percentage of drawn repeats tracts that are boundary-associated increased from 49.5% (bootstrapped 95% confidence interval [CI] : 30.3% < m percent_boundary < 68.6%) in matched repeats compared to 81.1% (bootstrapped 95% CI: 66.2% < m percent_boundary < 96.0%) in daSTRs, respectively (Figure 2C) . Finally, we conducted a randomization test and demonstrated that daSTRs are significantly closer to domain boundaries compared to the genome-wide null distribution of matched repeats (empirical p = 0.0001, Figure 2D ). Together, our data indicate that loci susceptible to pathologic, unstable repeat expansion are significantly closer to domain boundaries than expected genome-wide by matched, normal-length repeat sequences.
daSTRs Co-localize with TADs that Are Invariant across Somatic Cell Types We next set out to determine if the strong enrichment of daSTRs at domain boundaries was specific to ESCs or more generalizable across lineages. Due to the read depth and resolution limits of Hi-C data published to date, subTAD boundaries have not been reported genome-wide across multiple human cell types. Therefore, we focused on only Mb-scale TADs reported in an independent study by Schmitt et al. (2016) (STAR Methods) in human ESCs (n = 2,502) and ESC-derived differentiated cells including: mesendoderm (n = 2,479), mesenchymal stem cells (n = 2,290), neural progenitor cells (n = 2,378), and trophoblast-like cells (n = 2,435) (Schmitt et al., 2016) . We observed that the majority of daSTRs at the human ESC TAD boundaries reported in Schmitt et al. (2016) were also observed at boundaries invariant across the other four ESC-derived differentiated cell types ( Figure S2 ). Notably, a large number of daSTRs known to undergo paternal instability (McMurray, 2010; Pearson et al., 2005) co-localized to boundaries in mouse sperm and not in mouse oocytes (Du et al., 2017) , suggesting that daSTRs could be at boundaries at the developmental stage when germline expansion takes place ( Figure S3 ). Together, these results indicate that daSTRs are present at boundaries in embryonic and somatic cell lineages and also in at least one stage of spermatogenesis when daSTR instability is paternally inherited.
daSTRs Linked to Neurological Disorders Co-localize with Boundaries in Human Cortical Tissue To understand genome folding in a tissue relevant to the subset of STR expansions linked to neurological dysfunction (Table S1 ), we next analyzed recently published Hi-C data from human fetal cortical plate tissue (Won et al., 2016) . We applied the DI+HMM method to detect 2,102 TADs and the DI+HMM and 3DNetMod methods to identify the full sweep of 11,206 subTADs in human cortical plate Hi-C (Table S4 ; STAR Methods). We focused our analysis on the 23 daSTR loci that to our knowledge are associated with neurological or neuromuscular disorders. Consistent with our observations in human ES cells, we found 8 out of the 23 neurological daSTR loci were detected at TAD boundaries in human fetal cortical plate tissue ( Figure 3A ). An additional 8 and 5 daSTRs localized to subTAD and qualitatively apparent boundaries, respectively ( Figures 3B and S4A-S4C ). These results indicate that the majority of the neurological disease-associated daSTRs (21 out of 23) are located at domain boundaries in human cortical tissue ( Figure 3C ). Thus, although the target cell type(s) for many unstable repeat expansion disorders are unknown, the strong enrichment at boundaries regardless of tissue origin suggests that daSTR co-localization with boundaries might be robust across cell types relevant for disease pathology.
Due to the diversity of daSTR attributes (Tables S1, S2 , and S3), we sought to understand if a particular repeat class was driving the co-localization with boundaries. We stratified our daSTRs into 4 main groups: (1) a CAG repeat unit in exons or 5 0 UTR (n = 9), (2) a GCG repeat unit in exons or 5 0 UTR (n = 8), (3) repeat units in introns (n = 5), and (4) a CTG repeat unit in 3 0 UTRs (n = 3) (Table S3 ; STAR Methods). Although statistical power was restricted by the small size of the groups, all four classes of daSTRs showed enrichment at boundaries compared to other normal-length repeats matched by sequence and gene body location ( Figure S5A) (Dixon et al., 2012; Nora et al., 2012; Phillips-Cremins et al., 2013) . Notably, we also observed a marked increase in the density of CpG islands at boundaries versus non-boundaries, whereas classic repressive chromatin marks such as H3K9me3 were slightly depleted at boundaries compared to loci internal to domains. Two classes of boundaries emerge: boundaries with high CpG island density and boundaries depleted of CpG islands ( Figures S6C and S6D ). These results demonstrate that a subclass of TAD/subTAD boundaries represent hotspots in the genome of ultra-high density of CTCF occupancy and CpG islands. To understand the relationship between STRs, CpG islands, and boundaries, we stratified boundaries into those with daSTRs, those with normal-length matched repeat tracts, and those that do not contain repeats. Boundaries containing matched normal-length repeat tracts show a striking increase in CpG island density compared to boundaries without repeats (odds ratio = 3.92, Fisher's exact test, p = 1.69EÀ110, Figures  4A and 4B) . Importantly, daSTRs localize with boundaries exhibiting ultra-high CpG island density (blue spheres, Figure 4A ). Moreover, boundaries with daSTRs exhibit a dramatic increase in CpG island density even over the rigorous null of boundaries containing matched, normal-length repeats (odds ratio = 24.2, Fisher's exact test, p = 1.19EÀ8, Figure 4C ). All four classes of daSTRs co-localize with CpG island-rich boundaries, including STRs that did not specifically contain CpG dinucleotides in the repeat unit sequence ( Figure S5B ). These data uncover unique genetic and epigenetic features (high CpG island density, high CTCF occupancy) at chromatin boundaries where daSTRs become unstable in repeat expansion disorders.
We hypothesized that the combination of boundary placement and ultra-high density of CpG islands would earmark daSTR versus normal-length STR locations in the genome, whereas boundaries devoid of CpG islands or CpG islands internal to domains would not. To test this hypothesis, we revisited our original statistical tests (Figure 2 ) after stratifying the genome into (1) boundaries with %1 CpG islands, (2) boundaries with R3 CpG islands, and (3) CpG islands at non-boundary genomic locations. We found that daSTRs are significantly more enriched at CpGrich domain boundaries compared to normal-length matched STRs (Fisher's exact test: odds ratio = 10.4 and p = 1.4EÀ8; Cochran-Mantel-Haenszel test: odds ratio = 6.64; Figure 4D ). Importantly, there is no significant difference between matched repeats and daSTRs when the test is performed on CpG island-depleted boundaries (Fisher's exact test: odds ratio = 0.271 and p = 0.063; Cochran-Mantel-Haenszel test: odds ratio = 0.364; Figure 4E ) or CpG islands not at boundaries (Fisher's exact test: odds ratio = 0.531 and p = 0.57; Cochran-MantelHaenszel test: odds ratio = 0.407; Figure 4F ). We also computed bootstrapped confidence intervals and observed that the mean percentage of repeat tracts located at CpG island-rich boundaries was 3-fold higher at daSTRS (65.7%; bootstrapped 95% CI: 47.5% < m percent_boundary < 84.0%) compared to normal-length matched repeats (22.0%, bootstrapped 95% CI: 5.9% < m percent_boundary < 38.1%) ( Figure 4G ). The mean percentage of repeat tracts located at CpG island-depleted boundaries or CpG islands not at boundaries was similar between matched repeats and daSTRs, respectively (Figures 4H and 4I) . Our results are consistent with a working model in which the combination of ultra-high CpG island density and TAD boundary localization earmarks genomic locations susceptible to STR instability.
TAD Boundary at the FMR1 daSTR Is Ablated in Fragile X Syndrome CpG islands are generally hypomethylated in normal somatic cells and can acquire aberrant hypermethylation in disease (Robertson, 2005) . We reasoned that boundaries might be disrupted in unstable repeat expansion disorders given that: (1) daSTRs are hypermethylated in fragile X syndrome (FXS) and myotonic dystrophy (Burman et al., 1999; Malter et al., 1997; Wö hrle et al., 1998 Wö hrle et al., , 2001 ) and (2) DNA methylation disrupts occupancy of the key architectural protein CTCF (Renda et al., 2007) . We performed chromosome-conformation-capture-carbon-copy (5C) (Dostie and Dekker, 2007; Dostie et al., 2006) on B-lymphocytes from an FXS patient with $935 CGG repeats (GM09237 from the Coriell Cell Repository), his healthy male sibling (GM09236), and a genetically unrelated FXS male with $645 repeats (GM04025) ( Figure 5A ; Tables S5, S6 , and S7).
We observed severe topological disruption around the FMR1 daSTR in both FXS patient B cell lines compared to the healthy (legend continued on next page) sibling with normal-length repeats ( Figures 5B-5D ). First, a domain boundary separating FMR1 from the immediate upstream TAD in the healthy sibling was ablated in the $935 FXS patient ( Figures 5B and 5C , green bracket). Second, the specific loop connecting the TAD immediately upstream of FMR1 was absent in the $935 FXS patient (Figures 5B and 5C, upper green arrow) . Third, the small subTAD encompassing the FMR1 gene dissolves in the $935 FXS patient compared to the healthy sibling ( Figures 5B and 5C , lower green arrow). Finally, when plotting the difference between FXS and WT contact maps, it becomes evident that there is a strong depletion and enrichment of contacts between the FMR1 gene and downstream and upstream TADs, respectively (Figures 5B and 5C, blue and red stripes in fold change maps). All four topological phenotypes occurred in the second FXS patient with $645 repeats ( Figure 5D ). These results demonstrate that FMR1 is associated with the downstream TAD in healthy B cells and shifts to the upstream TAD in two patients with FXS.
To understand if the FMR1 topological disruption was generalizable to tissues affected in FXS, we performed 5C in human brain tissue from two unaffected males (control 1 and control 2, age of death 62 and 69, respectively) and two males diagnosed with FXS (case 1 and case 2, age of death 60 and 74, respectively) (Tables S5 and S6 ). We observed the same large-scale reorganization of the topological environment surrounding the FMR1 daSTR in human brain tissue as in B cells, including enrichment of contacts between FMR1 and upstream TAD and depletion of FMR1 contacts across the downstream TAD (Figures 5E , 5F, S7A, and S7B). We also observed boundary ablation in fibroblasts obtained from the same patient who contributed the B cells with $645 repeats (GM04024) compared to fibroblasts from a race-, gender-, and age-matched individual (AG06103) ( Figures S7C and S7D ). We quantified the boundary disruption across cell types and patients by plotting the directionality index (DI) ( Figure 5G ). FMR1 is biased toward downstream contacts (positive DI) in healthy individuals and transitions to upstream contacts (negative DI) in diseased individuals. Notably, we did not observe any difference in boundary structure between FXS patient and control B cells or brain tissue when examining domains distal to FMR1 (Figures 5H, S7E, and S7F), suggesting that loss of domain integrity in the FXS patient was specific to the genomic location of the daSTR. Together, these results reveal severe topological disruption at the FMR1 daSTR in at least three cell types and at least four patients with FXS.
CTCF Occupancy at the FMR1 daSTR Is Ablated in Fragile X Syndrome CTCF occupancy is disrupted at boundaries that lose structural integrity in diseases of limb development and cancer (Flavahan et al., 2016; Hnisz et al., 2016; Lupiá ñ ez et al., 2015) . To determine if CTCF was altered in the FXS patient samples, we performed chromatin immunoprecipitation sequencing (ChIP-seq) on the B cells from FXS patients with $935 (GM09237) and $645 (GM04025) CGG STRs and the healthy male sibling to GM09237 (GM09236) (Tables S5 and S6 ). CTCF occupancy was largely unchanged across the genome in these samples ( Figure 6A ). Notably, a doublet of occupied CTCF binding sites $100 kb upstream of the FMR1 daSTR in healthy B-lymphocytes was lost in both FXS patient samples ( Figure 6B ). The CTCF doublet is located directly at the base of the upstream loop and TAD boundary; disruption of these structural features in FXS patients correlated with lost CTCF occupancy . Consistent with the established principles of CTCF motif convergency (Rao et al., 2014) , the doublet CTCF sites contained CTCF motifs in the reverse orientation and looped to distal CTCF occupied motifs oriented in the forward direction ( Figures 6C and 6D ). We used Sanger sequencing to confirm that the loss of occupancy was not due to single nucleotide polymorphisms at the motifs ( Figure 6F ). We also noticed that the specific long-range contacts between FMR1 and the downstream TAD were lost in FXS but not mediated by CTCF (Figures 6E and S7G) , suggesting that additional architectural proteins are affected by repeat expansion. These results demonstrate that occupancy of a doublet CTCF motif over 100 kb from the FMR1 daSTR is lost in FXS patient samples at the genomic location of boundary disruption.
Boundary Disruption in Fragile X Syndrome Patients
Correlates with FMR1 Silencing FXS is caused by the loss of the fragile X mental retardation protein (FMRP) encoded by FMR1 (Verkerk et al., 1991) . The mutation-length CGG STR acquires DNA methylation, which is thought to cause FMR1 silencing (Park et al., 2015) . To understand the relationship between the topological changes and a molecular phenotype that is clinically relevant, we assessed FMR1 expression levels in all FXS patient samples. We also created 5C maps around the FMR1 daSTR in male patients with a mutation-length STR ($477 CGGs; GM06897) but with no silencing of the FMR1 gene compared to their healthy male sibling (normal-length repeats; GM06890) ( Figures S7H-S7K ). We found severe reduction of FMR1 expression in all FXS patient samples with boundary disruption, whereas boundaries remained intact if FMR1 was not silenced ( Figures 6G, 6H , and S7I-S7K). These results demonstrate that boundary disruption correlates with the pathological transcription silencing of FMR1 in FXS.
Finally, to better understand how the FXS topological changes might be connected to FMR1 trancriptional silencing, we mined published ChIP-seq data in GM12878 cells for H3K27ac, an established mark of active enhancers (Creyghton et al., 2010) . We found increased density of H3K27ac-positive putative enhancers in the downstream TAD and minimal H3K27ac signal in the TAD upstream of the FMR1 daSTR ( Figure 6I ). We hypothesize that the landscape of accessible enhancers is markedly (D-F) Bar plots comparing localization of daSTRs and matched repeats at or not at boundaries for (D) boundaries with R3 CpG islands, (E) boundaries depleted of CpG islands, and (F) CpG islands not at boundaries. (G-I) Bootstrapped distributions of percent daSTRs or matched repeats overlapping boundaries for (G) boundaries with R3 CpG islands, (H) A) 5C contact matrices in B-lymphocytes from a male with FXS with a full mutation of $935 CGG repeats (Coriell catalog ID GM09237), a healthy male sibling (GM09236), and a genetically unrelated male with FXS and with a full mutation of $645 CGG repeats in length (GM04025). (B and C) Zoomed-in 5C heatmaps on the FMR1 locus are shown for the B-lymphocytes from an FXS patient and healthy sibling. Zoom-ins show 3.2 MB (B) and 0.8 MB (C) around the FMR1 locus. The log fold change between the diseased and healthy sibling 5C highlights contacts gained (red) and depleted (blue). Green arrows point to loops lost in disease and green brackets annotate the region of increased interaction frequency indicative of boundary disruption. (D) Zoomed-in 5C heatmaps on the FMR1 locus for an additional genetically unrelated patient (645 repeats, Coriell catalog ID GM04025), and fold change map compared to sample GM09236. (E) 5C contact matrices in human cerebellum tissue from an unaffected individual (control 1, age of death 62) and from an individual with FXS (case 1, age of death 60). The FMR1 gene is highlighted in green and the repeat demarcated by a red vertical line. (F) Zoomed-in 5C heatmaps on the FMR1 locus for the brain samples shown in (B) . (G and H) A metric quantifying boundary strength, directionality index, is plotted at the FMR1 daSTR boundary (B1) (G) and a boundary distal from FMR1 (B2) (H) for affected and unaffected patient samples. See also Figure S7 and Tables S5, S6 , and S7. altered in FXS as FMR1 switches out of the downstream boundary and into the upstream boundary. It is tempting to speculate that the loss of FMR1 expression in FXS might in part be due to the shift of the gene from the downstream TAD containing active enhancers to the upstream TAD that is largely devoid of active elements.
DISCUSSION
In this work, we set out to gain insight into the epigenetic, genetic, and topological features that distinguish genomic locations known to undergo unstable STR expansion from the tens of thousands of normal-length STR tracts across the human genome. We find that 3D chromatin domain boundaries can be stratified into at least two groups: (1) those with high CpG island density and high occupancy of the architectural protein CTCF, and (2) those depleted of CpG island density. We discover that the majority of daSTRs are specifically targeted to CpG islandrich chromatin domain boundaries and not at boundaries depleted of CpG islands nor CpG islands internal to domains. We unexpectedly find that the boundary encompassing the FMR1 daSTR is ablated in FXS. The extent of boundary disruption correlates with loss of occupancy of two specific CTCF sites and silenced FMR1 expression. Together, these results reveal a new link between mutation-length daSTRs and the reconfiguration of 3D genome folding in repeat expansion disorders.
Based on our observations, we hypothesize that the genetic, epigenetic, and topological environment at CpG island-rich boundaries makes STRs unusually susceptible to instability compared to CpG island-depleted boundaries and all nonboundary locations in the genome ( Figure 7A ). This hypothesis opens up future studies aimed at elucidating the cause and effect relationship between STR instability and boundary integrity. We suggest three possible models to explain our findings: (1) STR instability occurs preferentially at CpG island-rich boundaries that largely remain intact in diseased individuals; boundaries are only disrupted in severe cases, such as the patients examined here, (2) STR instability occurs as a consequence of boundary disruption, or (3) STR instability occurs preferentially at CpG island-rich boundaries and causes topological misconfiguration upon expansion ( Figure 7B ).
Based on the striking co-localization of daSTRs with boundaries, we hypothesized that repeat expansion could disrupt TAD/subTAD structure. We show that in four unrelated patients, across two cell types and in brain tissue, the TAD boundary around the FMR1 daSTR is disrupted in FXS. This boundary disruption results in a dramatic re-organization of genome topology around the FMR1 gene, such that it no longer contacts genomic loci in the downstream TAD marked by histone modifications characteristic of active enhancers. Rather, FMR1 merges with the upstream TAD largely devoid of active enhancer marks, suggesting that the topological reconfiguration of the genome could be related to pathologic silencing of the FMR1 gene. Future work might reveal that TAD disruption occurs at other daSTRs and might potentially have downstream implications for which genes are misregulated in unstable repeat expansion disorders. An exciting area of future inquiry will be to elucidate whether boundary disruption causes and/or contributes to FMR1 transcriptional silencing or is only a consequence of FMR1 silencing ( Figure 7C ).
We additionally show that FMR1 TAD boundary disruption is correlated with disruption of CTCF occupancy. Our observations add a 3D component to the locus-specific evidence that STR instability is linked to alterations of CTCF occupancy (Brock et al., 1999; Cleary et al., 2010; Filippova et al., 2001; Libby et al., 2008; Sopher et al., 2011) . Disruption of a CTCF binding site at the Atxn7 locus leads to increased somatic and germline repeat instability in a transgenic mouse model of spinocerebellar ataxia 7 (Libby et al., 2008) . In congenital myotonic dystrophy, the region flanking the DM1 gene is hypermethylated and this methylation disrupts binding of adjacent CTCF binding sites (Filippova et al., 2001; Steinbach et al., 1998) . Moreover, CpG islands are aberrantly hypermethylated in a subset of cancers that exhibit microsatellite instability (Sharma et al., 2010; You and Jones, 2012) . Understanding the cause and effect relationship among boundary disruption, DNA methylation, CTCF occupancy, CpG islands, STR expansion, and gene expression will provide new insight into the molecular mechanisms governing genome instability and silencing in repeat expansion disorders ( Figures 7B and 7C) .
It is important to highlight that our study does not aim to elucidate the specific genetic variants that will predict the individuals who get repeat expansion disorders across a human population. Indeed, many of the daSTR-associated domain boundaries appear to be constitutive across healthy individuals, thus it remains an open question why only a small proportion of human individuals might undergo daSTR expansion at CpG island-rich boundary locations. We posit that STR instability at CpG island-rich boundaries manifests in individuals already genetically Figure S7 and Tables S5, S6, and S7. pre-disposed to repeat expansion. Studies in model organisms show that mutations in genes encoding key machinery involved in DNA replication, repair, and recombination are linked to STR instability (Iyer et al., 2015; McMurray, 2010; Mirkin, 2007; Pearson et al., 2005) . A recent genome-wide association study in Huntington's disease patients identified a link between genetic variation in DNA repair machinery and the age of onset of the disease (Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium, 2015). In our working model, the individuals with single nucleotide polymorphisms affecting critical genes encoding replication, recombination, or repair machinery may be more likely to develop repeat instability at CpG island-rich domain boundaries than those in the general population ( Figure 7A) . STR instability is known to occur in the germline, but tissuespecific somatic variation in STR tract length has been reported (Leeflang et al., 1995; Telenius et al., 1994; Wö hrle et al., 1993; Wong et al., 1995; Zhang et al., 1994) . Here, we find that Mb-scale TAD boundaries co-localized with daSTRs are constitutive across the somatic cell types analyzed in this study. Thus, daSTRs localized between constitutive TADs are likely to be placed at boundaries in the specific cell type(s) of origin relevant to each repeat expansion disorder. By contrast, many other daSTRS are colocalized to subTAD boundaries, which are known to be dynamically reconfigured across cell-state transitions in development (Norton et al., 2018) . As highresolution Hi-C data are published across a wide range of somatic cell types in coming years, it will be possible to determine if there is a link between somatic STR instability variation and cell-typespecific subTAD boundaries. Future studies focused on creating high-resolution genome folding maps at distinct stages in spermatogenesis and oogenesis (Pearson, 2003) will yield insight into the role for boundaries in the developmental timing of germline instability.
Recent high-resolution chromosomeconformation-capture sequencing studies have revealed that TAD boundaries are perturbed in rare human limb malformation diseases (Lupiá ñ ez et al., 2015) and certain types of cancers (Flavahan et al., 2016; Hnisz et al., 2016) , leading to enhancer miswiring and pathogenic disruption of gene expression. Here, we provide evidence suggesting that inherited human disorders driven by unstable repeat expansion might also be linked to patterns of higher-order genome folding. We demonstrate that although daSTRs exhibit diverse features, they share a common spatial placement at chromatin domain boundaries with ultra-high density CpG islands. We discover that the boundary at a specific daSTR in the FMR1 gene is disrupted in FXS in a manner that markedly alters the enhancer landscape accessible to the gene and correlates with FMR1 silencing. An exciting area of future inquiry will be to evaluate the cause and effect relationship between STR instability and domain boundary disruption, which may illuminate the potential of topology-directed therapy in treating disease.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Du, Z., Zheng, H., Huang, B., Ma, R., Wu, J., Zhang, X., He, J., Xiang, Y., Wang, Q., Li, Y., et al. (2017) . Allelic reprogramming of 3D chromatin architecture during early mammalian development. Nature 547, 232-235. 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents may be directed to and will be fulfilled by the Lead Contact, Jennifer E. Phillips-Cremins (jcremins@seas.upenn.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell Lines
All cell lines were obtained from the Coriell Institute for Medical Research Cell Repository. B-lymphocytes were grown at 37 C and 5% CO2 with 15% FBS in RPMI 1640 media with 2 mM glutamine and 1% penicillin-streptomycin-amphotericin. Cells were passaged every 3-4 days. Fibroblasts were grown at 37 C and 5% CO2 with 15% FBS in MEM Earles media with 2 mM glutamine and 1% penicillin-streptomycin-amphotericin and passaged every 5-7 days. All cell lines used were male.
Frozen human tissue acquisition
Frozen postmortem human cerebellum tissue from two male full mutation cases diagnosed with FXS (Table S5) were obtained from the Medical Investigation of Neurodevelopmental Disorders Institute Brain Repository at the University of California at Davis in Sacramento, CA, under approved IRB protocols (University of California, Davis). Frozen postmortem human cerebellum tissue from two male age-matched controls were obtained frozen from the Miami Brain Tissue Bank.
METHOD DETAILS
CTCF ChIP-seq CTCF ChIP-seq was performed as previously described (Beagan et al., 2017) . 20 million B-lymphocytes were fixed in serum-free RPMI 1640 in 1% formaldehyde for 10 minutes at room temperature. Fixation was terminated by adding glycine to a final concentration of 0.2 M and incubating for 5 minutes at room temperature. Cells were washed once with PBS and lysed by incubating on ice for 10 minutes in cell lysis buffer (10 mM Tris pH 8.0, 10 mM NaCl, 0.2% NP-40/Igepal, Protease Inhibitor, PMSF) followed by dounce homogenization, using 30 strokes. Lysed cells were pelleted and the resulting nuclei were lysed by re-suspending in 500 mL Nuclear Lysis Buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1% SDS, Protease Inhibitor, PMSF) and incubated on ice for 20 min. Samples were sonicated after adding 300 mL IP Dilution Buffer (20 mM Tris pH 8.0, 2 mM EDTA, 150 mM NaCl, 1% Triton X-100, 0.01% SDS, Protease Inhibitor, PMSF) using a QSonica Q800R2 sonicator for 1 hour set at 100% amplitude, with pulse set to 30 s on and 30 s off. After sonication, samples were pelleted and supernatant was transferred to pre-clearing reactions containing 3.7 mL IP Dilution Buffer, 500 mL Nuclear Lysis Buffer, 175 mL of a 1:1 ratio of ProteinA:ProteinG bead slurry and 50 ug of rabbit IgG. Samples were rotated at 4C for 2 hours. Next, 200 mL was aliquoted from the pre-cleared chromatin as the whole cell extract 'input' control. The remainder of the DNA was added to the pre-bound IP reaction consisting of 1mL cold PBS, 20 mL Protein A, 20 mL Protein G, and 10 mL CTCF antibody. Pre-binding of the IP reaction was performed the previous by rotation at 4C. Upon addition of DNA, IP reactions were rotated overnight at 4C.
IP reactions were pelleted, the supernatant was discarded, and the bead pellet was washed once with IP Wash Buffer 1 (20mM Tris pH 8, 2mM EDTA, 50 mM NaCl, 1% Triton X-100, 0.1% SDS), twice with High Salt Buffer (20 mM Tris pH 8, 2mM EDTA, 500 mM NaCl, 1% Triton X-100, 0.01% SDS), once with IP Wash Buffer 2 (10 mM Tris pH 8, 1mM EDTA, 0.25 M LiCl, 1% NP-40/Igepal, 1% sodium deoxycholate) and twice with TE buffer (10mM Tris pH 8, 1mM EDTA pH 8). Washed beads were eluted in Elution buffer (100mM NaHCO3, 1%SDS, prepared fresh) by resuspending and then spinning at 7,500 rpm. RNA was degraded with RNase A and incubated at 65C for 1 hour. To degrade residual DNA, proteinase K was added and all samples were incubated overnight at 65C. DNA was extracted using phenol:chloroform and then precipitated using sodium acetate and ethanol.
Libraries were prepared for sequencing using the NEBNext Ultra II Library Prep Kit for Illumina following the manufacturers protocol. 0.5 ng of DNA was used for starting material, which was quantified using Qubit dsDNA HS Assay Kit. No size selection step was performed after adaptor ligation. Libraries were amplified over 11 PCR cycles using NEBNext Multiplex Oligos for Illumina. High sensitivity electrophoresis was performed on an Agilent 2100 Bioanalyzer to confirm the library size of 250 to 1200 bp. Library concentration was assayed via the KAPA Illumina Library Quantification Kit and diluted to equivalent concentrations. Pooled libraries were sequenced using a 75-cycle paired-end kit on a Illumina NextSeq 500.
5C library generation and sequencing 3C libraries were created as previously described (Rao et al., 2014) . Briefly, 4 million cells were collected per library and fixed with 11% formaldehyde to a final concentration of 1% at room temperature for 10 min. Formaldehyde was quenched by addition of 2.5 M glycine to a final concentration of 0.2 M for 5 min. Cells were washed in PBS and cell pellets were then flash-frozen in liquid nitrogen. Cross-linked pellets were lysed (10mM Tris-HCl pH 8.0, 10mM NaCl, 0.2% NP-40, protease inhibitors) for 15 min. After spinning at 2,500 g for 5 min, supernatant was discarded and pelleted nuclei were washed again with cellular lysis buffer. Chromatin was solubilized in 50 mL 0.5% SDS and incubated at 62 C for 10 min. SDS was quenched with 145 mL of water and 25 mL of 10% Triton X-100 and incubated at 37 C for 15 min. Nuclei were digested with 100 U of HindIII at 37 C overnight. HindIII was then inactivated at 62 C for 20 min. HindIII digested chromatin was ligated at 16 C for 2 hours in ligation mix (100 mL 10% Triton X-100, 120 mL 10x NEB T4 DNA Ligation buffer, 12 mL 10 mg/ml BSA, 718 mL water and 2000U T4 DNA Ligase). After spinning at 2,500 g for 5 min, the supernatant was discarded and the pellet was resuspended in nuclear lysis buffer (10mM Tris-Hcl pH 8.0, 0.5M NaCl, 1.0% SDS). Crosslinks were reversed with the addition of Proteinase K and incubated at 65 C for 4 hours, before additional Proteinase K was added and incubated at 65 C overnight. Prior to DNA extraction, RNaseA was used to degrade RNA. DNA was extracted with 350 mL phenol:chloroform and precipitated with sodium acetate and ethanol. Excess salt was removed using Amicon Ultra centrifugal filter unit. 5C libraries were created as previously described (Beagan et al., 2016 (Beagan et al., , 2017 . Double-alternating 5C primers were designed to a 6.4 Mb-sized region around the FMR1 locus in the hg19 reference genome with the my5C primer design software (Table S7) . Primers were denatured at 95 C for 5 min and then annealed to the 3C template at 55 C for 16 h. Annealed 5C primers were ligated across HindIII sites via incubation with 10 U of Taq Ligase at 55 C for 1 h. Taq Ligase was then inactivated at 75 C for 10 min. Ligation products were combined with PCR mix (5 mL 5x HF buffer, 0.2 mL 25mM dNTP, 1.5 mL 80 mM Emusion forward primers, 1.5 mL 80 mM Emulsion phosphorylated reverse primers, 0.25 mL Phusion polymerase (NEB), 10.55 mL water) and amplified in 3 stages: 1 cycle -95 C for 5 min, 30 cycles -98 C for 10 s, 62 C for 30 s, 72 C for 30 s, 1 cycle -72 C for 10 min, 4 C thereafter. Size selection of the 100 bp 5C library was performed using AMPure XP beads and library preparation was performed with NEBNext Ultra DNA Library Prep Kit according to manufacturer protocol (NEB #7370). Libraries were sequenced on Illumina NextSeq 500 according to the manufacturer's instruction.
Frozen tissue processing
Flash frozen human tissue was first pulverized using the CP01 Cryoprep Manual Pulverizer by transferring 20 mg of frozen tissue into Covaris TT1 tissue tubes, placing the tube in the Cryoprep Pulverizer, and hitting with a hammer 5 times. The pulverized tissue was reconstituted in 10 mL of cold PBS and fixed in 1% formaldehyde for 10 minutes at room temperature. Fixation was terminated by adding glycine to a final concentration of 0.2 M glycine and incubating for 5 minutes at room temperature. The resulting pellet was spun down, the supernatant removed and washed once with PBS. The pellet was then used for CTCF ChIP-seq and 5C in the same manner as with a cell pellet.
Gene expression quantification via qRT-PCR FMR1 and GAPDH expression was quantified in all cell lines used using qRT-PCR as previously described (Beagan et al., 2017) . Briefly, RNA isolation was performed using the mirVana miRNA isolation kit following manufacturers protocol precisely for total RNA isolation on 500,000 cells. cDNA was prepared for each sample by loading 100 ng of RNA, quantified via Qubit RNA HS assay kit, into the SuperScript First-Strand Synthesis System according to manufacturer's specifications. A standard curve was generated for each gene by amplifying cDNA with gene-specific primers using a conventional PCR reaction (see Key Resources Table for primer sequences). The amplicon was size-selected and quantified using the Qubit dsRNA HS assay kit. Standards were created with serial dilutions of 200 -0.0002 pM standards. qRT-PCR reactions were performed on the Applied Biosystems StepOnePlus system using the Power SybrGreen PCR Master Mix according to manufacturer recommendations. For each qRT-PCR reaction, primers were added to a final concentration of 400 nM and 1 mL of each standard or sample cDNA was loaded. The resulting CT values of the standards were used to generate a standard curve and compute the absolute concentration of mRNA transcripts per condition using 100 ng of RNA in the cDNA reaction.
Sanger sequencing of key regions
From the CTCF ChIP-seq data, we identified two key peaks (three motifs) where CTCF occupancy was differential around FMR1 between samples from healthy controls and those from patients diagnosed with Fragile X Syndrome. We designed primers to PCR amplify an area of around 500 bps around each peak (See Key Resources Table) and performed conventional PCR on DNA extracted using the QIAGEN DNeasy Blood and Tissue kit following manufacturers protocol precisely for total DNA isolation on 500,000 cells. We then gel extracted the PCR products of interest using a QIAGEN Gel Extraction Kit following manufacturer's protocol and submitted them to Genewiz for Sanger sequencing.
QUANTIFICATION AND STATISTICAL ANALYSIS
CTCF ChIP-seq data mapping and processing Paired-end reads were mapped to the reference human genome (hg19) using bowtie (Tables S5 and S6A ). Reads were analyzed if they had two or fewer reportable alignments. To facilitate the comparison of ChIPseq libraries across cell types, the mapped reads were filtered to remove optical and PCR duplicates and then downsampled to equivalent read numbers across cellular states. Peaks were identified using Model-based Analysis for ChIP Sequencing v2.0 (MACS2) using default parameters. For CTCF ChIPseq, default parameters were used with a p value cutoff of p < 1E-8 (number of peaks called in Tables S5 and S6A ).
5C data mapping and processing Paired-end reads were mapped to a pseudo-reference genome representing all possible 5C primer ligation junctions as previously described (Beagan et al., 2016 (Beagan et al., , 2016 Phillips-Cremins et al., 2013) (Table S6B ). Counts files were assembled by tallying the number of reads for each 5C primer junction. Raw 5C counts distributions were quantile normalized to address minor sequencing depth differences. Next, ligation-junction resolution counts were converted to restriction fragment resolution counts by averaging the reads from the ligation junctions tallied for each restriction fragment. An NxN matrix of fragment-level 5C counts, where N is the number of fragments in the FMR1 region queried by the double alternating primers, was then binned into 4 kb bins with a 12 kb smoothing window using sum-binning. Finally, restriction fragment biases were normalized by applying matrix balancing as previously reported (Imakaev et al., 2012) .
Topologically associating domain (TAD) detection
To identify Mb-scale TADs as previously reported (Dixon et al., 2012) , we ran the DI-HMM method using a DI window of 50 as previously described on human ES cell Hi-C data previously published (Dixon et al., 2012) . In brief, the DI-HMM method computes a directionality index (DI) for genomic intervals that reflects the degree of upstream or downstream bias. A hidden Markov model (HMM) is used to determine ''true'' upstream or downstream biased states. A domain is initiated at the beginning of a single downstream biased HMM state and ends at the last of an upstream biased HMM state. TAD calls were obtained using a DI parameter of 50, corresponding to a genomic interval of 2 Mb (50 bins times 40 kb resolution). For human cortical plate fetal tissue, normalized Hi-C reads were obtained from Won et al. (2016) and the DI-HMM method applied as with human ES cells.
Identification of the nested hierarchy of TADs/subTADs
To identify the nested hierarchy of TADs and subTADs, we used a combination of the DI+HMM method with DI window 50 to yield Mb-scale TADs (Dixon et al., 2012) and our newly published subTAD calling method 3DNetMod . For human cortical plate tissue, we concatenated DI+HMM calls for TADs at the DI50 window (Table S4C ) with 3DNetMod subTAD calls (Table S4E) to get final calls (Table S4G ). Parameters used were: plateau size 3, 6MB regions with 4 MB overlap, chaos filter between 0.85 and 1.1, variance thresholds of 0-400 (0.6415789), 401-800 (15.25789), 801-1600 (3.889474), 1601-3000 (0.2578947), 3001-120000 (0) . For human ES cell data, we concatenated DI+HMM calls for TADs at the DI50 window (Table S4B ) with 3DNetMod sub-TAD calls (Table S4D) to get final calls (Table S4F ). Parameters used were: plateau size 3, 6MB regions with 4 MB overlap, bad region removal of 0.05% or higher zeros in diagonal or > 3 consecutive zeros, chaos filter between 0.85 and 1.1 and variance thresholds of 0-400 kb (0.626), 401-800 kb (6.836), 801-1600 kb (15.5437), 1601-3000 kb (0.3631) and 3001-120000 kb (0).
Methodology for boundary identification
To account redundant domain calls, we merge overlapping boundaries to create a final, non-redundant, unique boundary list (human cortical plate tissue (Table S4I) ; human ES cells (Table S4H) ). We start with the full list of DI+HMM plus 3DNetMod domain calls and compute boundaries as the edge coordinate of each domain ± 40kb on either side. All boundaries that overlapped and were the same direction (i.e, upstream or downstream) were then merged into a singular new boundary in which the new genomic coordinates were the midpoint ± 60kb on either side. Therefore, the final size of all boundaries is 120kb. The 120kb boundary size was chosen to address the resolution limit of the Hi-C assays, 40 kb, used in this study.
Cell type specific TAD boundary identification TAD boundaries from H1 ES cell (Human H1) and H1 ES cell-derived lineages-mesendoderm (MES), mesenchymal stem cells (MSC), neural progenitor cells (NPC), and trophoblast-like cells (TRO)-were obtained from Schmitt et al. (2016) . We used these published Mb-scale TAD calls in Figure S2 because Schmitt et al. (2016) used an independent study and an independent TAD calling method to compare TADs across H1 ES cell (Human H1) and H1 ESC-derived lineages-mesendoderm (MES), mesenchymal stem cells (MSC), neural progenitor cells (NPC), and trophoblast-like cells (TRO).
Germline Hi-C map generation Contact frequency maps from mouse sperm and early murine development were obtained from Du et al. (2017) , GEO: GSE82185.
Selection of disease-associated STR (daSTR) genes for analysis A total of 29 genes associated with trinucleotide repeat expansion disorders were initially selected for analysis based on previous reports (Tables S1, S2 , and S3) (Iyer et al., 2015; La Spada and Taylor, 2010) . Of these 29, two (TBP, NOP56) were dropped from our analyses because they were located at the far edges of chromosomes beyond where Hi-C can query domains. One final gene (CSTB) was queried for boundary localization but dropped from all analyses that compared daSTRs to matched, normal-length repeats because there are no other repeats matching its sequence, length, and gene body location requirements in hg19. Thus, we were able to generate contact frequency heatmaps around 27 daSTRs, and use 26 daSTRs for statistical analyses.
Identification of the sequence of disease-associated STRs (daSTRs) and matched repeats For each daSTR tract analyzed in this manuscript, the location of the longest contiguous stretch of the relevant repeat unit in the reported location within the body of the gene of interest was determined using the hg19 reference genome (Table S2) . Coordinates of genes, exons, introns, and UTRs were obtained from UCSC Table Browser based on RefSeq genes downloaded in April 15, 2017. For each daSTR, we identified a set of matched repeats. Matched repeats for each daSTR are repeat tracts in hg19 that share the same repeat unit, are located in the same region within the gene body, and are at least 5 repeat units in length, and do not exceed the maximum length for ''normal'' for that gene (Tables S1, S2 , and S3).
Classifying disease-associated STR (daSTR) genes into 4 key classes The 26 daSTR tracts were further subdivided into 4 classes based on the repeat unit and location of the repeat in the gene body (Table S3 ) so that these classes could be analyzed individually. These groups are motivated by prior literature showing that daSTRs with similar sequence and gene body locations behave similarly with respect to number of repeats required for disease and expansion mechanisms (Iyer et al., 2015) . The classes are: (1) Repeat unit CAG in exons and 5 0 UTRs (9 daSTRs), (2) Repeat unit GCG/CGG in exons and 5 0 UTRs (8 daSTRs), (3) Unique repeat units in introns (5 daSTRs), and (4) CTG introns in 3 0 UTRs (3 daSTRs).
Determining repeat localization and distance to boundary Distance from a repeat to the nearest domain boundary was calculated as the minimum distance from either end of the repeat to its closest boundary. Repeats contained within a boundary are given distance of 0 base pairs (bp). A repeat is classified as 'boundary localized' if it overlaps the boundary by one or more base pairs.
Determining CpG island, CTCF, and H3K9me3 content across the genome We partitioned the hg19 reference genome into sequential 120kb bins using bedtools makewindows. Any bin that overlapped a domain boundary present in either H1 ES cell (Human H1), H1 ES cell-derived lineages (mesendoderm (MES), mesenchymal stem cells (MSC), neural progenitor cells (NPC), and trophoblast-like cells (TRO), or human cortical plate neurons was removed from the list of bins. Bins overlapping centromeres, telomeres, gene deserts (areas of the genome > 2 Mb with no genes) and regions not able to be queried (ie, ends of chromosomes) by Hi-C were also removed. The remaining bins are considered non-boundary. This method ensures that both boundaries and non-boundary bins are the same size, and that non-boundary bins are not dominated by hard to query regions of the genome. The number of CpG islands, CTCF peaks and H3K9me3 peaks per H1 ESC 120kb domain boundary and 120kb non-boundary bin was determined using bedtools intersect. Centromeres and telomeres were obtained from USCS Table Browser . Genes were from the RefSeq gene track on USCS were not artifacts of using a null repeat set that was not weighted similarly to the daSTRs set with respect to STR type group (Table S3) , we also randomly created n = 1000 subsets of the null repeat set that were weighted similarly to the daSTRs. We then used the Python StatsModel package implementation of the Cochran-Mantel-Haenszel test on the 1000 subsets to calculate a pooled odds ratio of the empirical distribution.
Randomization tests for boundary localization and CpG island density
The null distribution was created by taking 10,000 draws without replacement of n = 26 matched repeats, where each draw is proportionally matched to the daSTR group with respect to repeat unit sequence and gene body location, and computing the test statistic each time. Two test statistics were used: (i) the percent of repeats that were located at a boundary ( Figure 2 ) and (ii) the number of CpG islands present in boundaries containing repeats (Figure 4 ). The distribution of the draws from the normal-length, matched repeats matched that of the daSTRs such that each unique combination of repeat unit and gene body placement is represented in the null group with the same proportions it is represented in the daSTRs group.
Pileups of CTCF/CpG density around domain boundaries
Pileup plots illustrating the number of CTCF/CpG sites centered on the middle of boundaries were generated by counting the number of CTCF/CpG sites in 120kb genomic bins flanking the center of the boundary and averaging this number by the total number of domain boundaries.
Calculation of DI in 5C datasets
To determine the directional bias of the bins containing FMR1 as well as the control region among the 5C datasets, we used the Directionality Index (DI) as described previously (Dixon et al., 2012) . Briefly, the directionality index is a weighted ratio between the number of 5C reads that map from a given 40kb bin to the upstream region and the downstream region. In order to perform this calculation within the limit imposed by our 5C region size, we used 600KB upstream and downstream in the calculation (the maximum possible for the control region).
DATA AND SOFTWARE AVAILABILITY
The accession number for the data reported in this paper is GEO: GSE111170. Custom code used to identify repeats in hg19 and perform statistical tests is available upon request. (A) Percent of daSTRs overlapping boundaries compared to a randomly sampled null distribution consisting of normal-length repeats stratified by four major repeat classes (detailed in Table S1 and STAR Methods). (B) Contour density plots depicting number of CTCF sites and CpG islands in boundaries containing specific daSTR classes (Table S1 ). daSTRs are marked in blue. 
